EPA0100 | Serum level of Macrophage migration Inhibitory Factor (MIF) is elevated during acute COVID-19 but not associated with severity, in donors from a biobank from Buenos Aires, Argentina | E-poster | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
EPB0286 | Serological responses to primary course and booster SARS-CoV2 vaccination in people with HIV: the SCAPE-HIV study | E-poster | SARS-CoV-2, COVID-19 and HIV |
EPC0522 | Sentinel surveillance for early detection of COVID-19 in Malawi | E-poster | Epidemiology of COVID-19 |
EPC0328 | Self-reported noncommunicable disease prevalence among older people living with HIV in Southern Africa | E-poster | Surveillance: Measuring the HIV epidemic |
EPD0616 | Self-disclosure of HIV serostatus significantly affected the willingness to provide dental care among dentists in Taiwan | E-poster | Social, political, legal and behavioural determinants of health in different contexts |
EPB0181 | Self collected HPV samples can reliably be used in women living with HIV (WLHIV) | E-poster | Co-morbidities |
EPB0169 | Selected comorbidities and the risk of ART switch in the context of HIV-RNA suppressed to ≤50 copies/mL | E-poster | Co-morbidities |
MOPEB20 | Sedative drug burden is associated with concurrent physical frailty in people aging with HIV in Canada: findings from the Positive Brain Health Now Study (+BHN) | Poster exhibition | HIV and ageing |
TUPEC14 | Secondary distribution of HIV self-test kits from males to their female sexual partners in two fishing communities in rural Uganda: results from the PEST4MEN pilot study | Poster exhibition | HIV testing |
TUPEE12 | Scaling-up cervical cancer prevention: Catholic Relief Services (CRS) Epidemic Control 90-90-90 (EpiC 3-90) project in Zambia | Poster exhibition | Integration of HIV services with other health and support services |